Green Vision Biotechnology Corp. (GVBT) financial statements (2021 and earlier)

Company profile

Business Address ROOMS 1804-06, 18/F, WING ON HOUSE
HONG KONG SAR, 00000
State of Incorp. NV
Fiscal Year End December 31
SIC 287 - Agricultural Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
1/31/2017
1/31/2016
1/31/2015
1/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments62939  020
Cash and cash equivalents62939  020
Receivables312165    
Inventory, net of allowances, customer advances and progress billings  278   
Inventory  278    
Other undisclosed current assets6646    
Total current assets:9937428  020
Noncurrent Assets
Property, plant and equipment2,1612,3633,013    
Intangible assets, net (including goodwill)793827883   
Intangible assets, net (excluding goodwill)793827883    
Other undisclosed noncurrent assets2240    
Total noncurrent assets:2,9563,1923,937    
TOTAL ASSETS:3,0553,2284,365  020
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:22123421372  
Accounts payable262831    
Accrued liabilities183149152    
Employee-related liabilities123420    
Taxes payable02310    
Other undisclosed accounts payable and accrued liabilities   72  
Debt   50 176
Due to related parties5,5905,3105,3015035  
Customer advances and deposits0   
Other liabilities2443847    
Other undisclosed current liabilities3,9154,0513,896    
Total current liabilities:9,9709,6349,45710737176
Noncurrent Liabilities
Total liabilities:9,9709,6349,45710737176
Stockholders' equity
Stockholders' equity attributable to parent(6,915)(6,405)(5,092)(107)(37)(17)14
Common stock16116116161666
Additional paid in capital(282)(282)(282)(17)382121
Accumulated other comprehensive loss(51)(38)(88)    
Accumulated deficit(6,742)(6,245)(4,883)(151)(81)(43)(12)
Total stockholders' equity:(6,915)(6,405)(5,092)(107)(37)(17)14
TOTAL LIABILITIES AND EQUITY:3,0553,2284,365  020

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
1/31/2017
1/31/2016
1/31/2015
1/31/2014
Revenues80100135   4
Revenue, net135    
Cost of revenue
(Cost of Goods and Services Sold)
(68)(78)(82)    
Gross profit:122153   4
Operating expenses(551)678(1,994)(70)(38)(31)(13)
Other undisclosed operating loss (1,758)     
Operating loss:(538)(1,059)(1,941)(70)(38)(31)(9)
Nonoperating income44377258    
Other nonoperating income44377260    
Interest and debt expense(2)3     
Net loss:(497)(679)(1,683)(70)(38)(31)(9)
Other undisclosed net income (loss) attributable to parent0(683)     
Net loss available to common stockholders, diluted:(497)(1,362)(1,683)(70)(38)(31)(9)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
1/31/2017
1/31/2016
1/31/2015
1/31/2014
Net loss:(497)(679)(1,683)(70)(38)(31)(9)
Other comprehensive income (loss)13(49)87    
Comprehensive loss:(484)(728)(1,597)(70)(38)(31)(9)
Other undisclosed comprehensive loss, net of tax, attributable to parent(25)(585)     
Comprehensive loss, net of tax, attributable to parent:(509)(1,313)(1,597)(70)(38)(31)(9)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: